Unknown

Dataset Information

0

11?-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.


ABSTRACT: Glucocorticoid action on target tissues is determined by the density of "nuclear" receptors and intracellular metabolism by the two isozymes of 11?-hydroxysteroid dehydrogenase (11?-HSD) which catalyze interconversion of active cortisol and corticosterone with inert cortisone and 11-dehydrocorticosterone. 11?-HSD type 1, a predominant reductase in most intact cells, catalyzes the regeneration of active glucocorticoids, thus amplifying cellular action. 11?-HSD1 is widely expressed in liver, adipose tissue, muscle, pancreatic islets, adult brain, inflammatory cells, and gonads. 11?-HSD1 is selectively elevated in adipose tissue in obesity where it contributes to metabolic complications. Similarly, 11?-HSD1 is elevated in the ageing brain where it exacerbates glucocorticoid-associated cognitive decline. Deficiency or selective inhibition of 11?-HSD1 improves multiple metabolic syndrome parameters in rodent models and human clinical trials and similarly improves cognitive function with ageing. The efficacy of inhibitors in human therapy remains unclear. 11?-HSD2 is a high-affinity dehydrogenase that inactivates glucocorticoids. In the distal nephron, 11?-HSD2 ensures that only aldosterone is an agonist at mineralocorticoid receptors (MR). 11?-HSD2 inhibition or genetic deficiency causes apparent mineralocorticoid excess and hypertension due to inappropriate glucocorticoid activation of renal MR. The placenta and fetus also highly express 11?-HSD2 which, by inactivating glucocorticoids, prevents premature maturation of fetal tissues and consequent developmental "programming." The role of 11?-HSD2 as a marker of programming is being explored. The 11?-HSDs thus illuminate the emerging biology of intracrine control, afford important insights into human pathogenesis, and offer new tissue-restricted therapeutic avenues.

SUBMITTER: Chapman K 

PROVIDER: S-EPMC3962546 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Chapman Karen K   Holmes Megan M   Seckl Jonathan J  

Physiological reviews 20130701 3


Glucocorticoid action on target tissues is determined by the density of "nuclear" receptors and intracellular metabolism by the two isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD) which catalyze interconversion of active cortisol and corticosterone with inert cortisone and 11-dehydrocorticosterone. 11β-HSD type 1, a predominant reductase in most intact cells, catalyzes the regeneration of active glucocorticoids, thus amplifying cellular action. 11β-HSD1 is widely expressed in liver, adipo  ...[more]

Similar Datasets

| S-EPMC4847593 | biostudies-literature
| S-EPMC5686277 | biostudies-literature
| S-EPMC3149101 | biostudies-literature
| S-EPMC9264407 | biostudies-literature
| S-EPMC7996314 | biostudies-literature
| S-EPMC2720031 | biostudies-literature
| S-EPMC6038918 | biostudies-literature